Corporate wellness programs have evolved from optional employee perks to essential elements of workplace culture, as companies increasingly recognize their role in improving employee health, productivity, and overall organizational performance. In 2023, the corporate wellness market reached a value of USD 73.33 billion, driven by the growing need to manage chronic diseases and promote mental…
The haemophilia treatment market has shown significant expansion, reaching USD 14.84 billion in 2023, and is projected to grow at an impressive CAGR of 7.5%, potentially reaching USD 28.44 billion by 2032. This growth is underpinned by key factors such as innovative therapies, a growing patient population, and increased awareness of haemophilia care across the…
The allogeneic T cell therapies market is gaining momentum, especially as an emerging frontier in cancer treatment and immune disorders. The promise of using healthy donor T cells to boost a patient’s immune response against diseases such as cancer, autoimmune conditions, and infectious diseases is driving significant interest in this space. Market forecasts suggest a robust CAGR of…
Giant Cell Arteritis (GCA) is an autoimmune vasculitis that predominantly affects the elderly, particularly those over 50 years of age. It causes inflammation in large and medium-sized arteries, especially the temporal arteries in the scalp and head. If left untreated, GCA can lead to severe complications like permanent vision loss, stroke, or aneurysm. The growing…
The behavioural health market, valued at USD 171.11 billion in 2023, is rapidly evolving, driven by growing awareness and acceptance of mental health issues. Rising incidences of mental disorders, coupled with increasing demand for integrated behavioural healthcare, are expected to propel market growth to USD 252.11 billion by 2032, reflecting a CAGR of 4.4% over the forecast period. In this…
The North America hospital stretchers market, valued at USD 2.9 billion in 2023, is set for significant expansion. This growth is attributed to the rising demand for technologically advanced stretchers, enhanced healthcare infrastructure, and the increasing focus on patient safety and comfort. The market is projected to grow at a CAGR of 5.37% during the…
As the world increasingly focuses on brain health, mental performance, and cognitive enhancement, nootropics—often referred to as smart drugs—are gaining traction. The nootropics market has expanded rapidly, reaching a value of USD 3.01 billion in 2023 and projected to grow at a CAGR of 14.6% over the forecast period, with the market expected to hit USD 10.28 billion by 2032. This blog…